Public hearings May 15, 2012 at Senate HELP committee. “De-linkage” proposals are an alternative to intellectual property that separate the market for R&D from the market for pills. De-linkage has surprising support from academics, health access advocates and drug companies.
Prior TIE coverage here. Much more extensive materials from Jamie Love/KEI here.
@koutterson
